Search by Compound Name
Compounds Sorted by Binding Targets per Compound
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 2930 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55
56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 73 74 75 76 77 79 81 84 86 89 95
96 100 108 109 120 124 130 137 143 154 156 168 186 224 240 259 276 278 284 303
304 310 315 323 339 369 370 371 372 373 374 375 376 377 378 380 381 383 384
385 386 388 389 390 391 392 393 394 395 397 398 401 403 404 406 408 418 427
429 443 447 515
Compounds Sorted Alphabetically
Compound Name (alphabetical)
Binding Targets
Enz. Inhib. Data
ITC Data
Alternate Compound Names
- Bile salt export pump
- Canalicular multispecific organic anion transporter 1
- Canalicular multispecific organic anion transporter 2
- Cytochrome P450 19A1
- Multidrug resistance-associated protein 4
- Uridine-5'-diphosphoglucuronosyltransferase 1A4
- 2-[3-(1-cyano-1-methylethyl)-5-(1H-1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropanenitrile
- 2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methyl-propanenitrile
- ANASTROZOLE
- CHEMBL1399
- NSC719344
- arimidex
- PAK 1/CDC42
- Serine/threonine-protein kinase PAK 4
- Serine/threonine-protein kinase PAK6
- Serine/threonine-protein kinase PAK7
- p21-Activated kinase 2 (PAK2)
- p21-Activated kinase 3 (PAK3)
- US8530652, 114
- Caspase-2
- Caspase-3
- Caspase-6
- Caspase-7
- Caspase-8
- Heat shock protein HSP 90-beta
6 IC50
- 1,2,3,4-tetrahydroisoquinoline-1,3,4-trione
- Isoquinoline-1,3,4-trione 1
- hsp90_153
- 5-hydroxytryptamine receptor 1A
- Acetylcholinesterase
- Adrenergic alpha1B
- Alpha-1A adrenergic receptor
- Alpha-1D adrenergic receptor
- Carboxylic ester hydrolase
- Bivalent 4-Aminoquinoline 9f
- N,N-di-4-Quinolyl-1,7-diaminoheptane dihydrochloride
- N-[7-(quinolin-4-ylamino)heptyl]quinolin-4-amine dihydrochloride
- Dual specificity mitogen-activated protein kinase kinase 1
- Dual specificity mitogen-activated protein kinase kinase 1/Mitogen-activated protein kinase 1/RAF proto-oncogene serine/threonine-protein kinase
- Dual specificity mitogen-activated protein kinase kinase; MEK1/2
- Mitogen-activated protein kinase 1
- Mitogen-activated protein kinase kinase kinase 8
- Serine/threonine-protein kinase B-raf
- CHEMBL507361
- US8575391, Q
- Acetylcholinesterase
- Aldose reductase (AR)
- Cholinesterases
- SUMO1 activating enzyme subunit 1
- eukaryotic translation initiation factor 4 gamma, 1 isoform 4
- hexokinase
- 5-(1,2-dithiolan-3-yl)pentanoic acid
- CHEMBL33864
- D,L-Lipoic acid
- D,L-Thioctic acid
- cid_864
- lipoic acid (LA)
- 5-hydroxytryptamine 1D receptor (5HT1D)
- Nitric oxide synthase, brain
- Nitric oxide synthase, endothelial
- Nitric oxide synthase, inducible
- Nitric-oxide synthase, brain
- Serotonin 1B/1D receptor
9 IC50
- CHEMBL1957349
- US8586620, 42
- 12-Lipoxygenase (12-LOX)
- 15-Lipoxygenase-2 (15-LOX-2)
- Arachidonate 15-lipoxygenase
- Arachidonate 5-lipoxygenase
- Cyclooxygenase
- Prostaglandin G/H synthase (cyclooxygenase)
7 IC50
- 3‐(3‐chlorophenyl)‐6,7‐dihydroxy‐4H‐chromen‐4‐one
- 6,7-Dihydroxy-3′-chloro-isoflavone (1c)
- IR-8
- 12-Lipoxygenase (12-LOX)
- 15-Lipoxygenase-2 (15-LOX-2)
- Arachidonate 15-lipoxygenase
- Arachidonate 5-lipoxygenase
- Cyclooxygenase
- Prostaglandin G/H synthase (cyclooxygenase)
7 IC50
- 3‐(4‐methylphenyl)‐3,4‐dihydro‐2H‐1‐benzopyran‐7,8‐ diol
- 7,8-Dihydroxy-4′-methylisoflavan (5b)
- HIR-303
- 12-Lipoxygenase (12-LOX)
- 15-Lipoxygenase-2 (15-LOX-2)
- Arachidonate 15-lipoxygenase
- Arachidonate 5-lipoxygenase
- Cyclooxygenase
- Prostaglandin G/H synthase (cyclooxygenase)
7 IC50
- 3‐(3‐methylphenyl)‐3,4‐dihydro‐2H‐1‐benzopyran‐7,8‐ diol
- 7,8-Dihydroxy-3′-methylisoflavan (5c)
- HIR-309
- Cytochrome P450 2C9
- Cytochrome P450 2D6 (2D6)
- Cytochrome P450 3A
- Nuclear receptor subfamily 1 group I member 2
- Orexin receptor type 1
- Orexin receptor type 2
- US8592457, 7-5
- 11-beta-hydroxysteroid dehydrogenase
- 11-beta-hydroxysteroid dehydrogenase 1
- Cytochrome P450 2C19
- Cytochrome P450 2C9
- Cytochrome P450 2D6
- Cytochrome P450 3A
11 IC50
- US8575157, 37
- Egl nine homolog 1
- Hypoxia-inducible factor 1 (FIH)
- Prolyl 3-hydroxylase OGFOD1
- Prolyl 4-hydroxylase
- Prolyl hydroxylase EGLN3
- Vascular endothelial growth factor A
- US8598210, 119
- US8598210, Table XV, 10
- US8598210, Table XV, 11
- US8722895, 10: {[5-(3-Chlorophenyl)-3-hydroxypyridine-2- carbonyl]amino}-acetic acid trifluoroacetic acid salt
- US8722895, 11: {[5-(3-Chlorophenyl)-3-hydroxypyridine-2- carbonyl]amino}-acetic acid
- US9598370, Example 00136
- USRE47437, Example {[5-(3-Chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}-acetic acid
- Acetylcholinesterase
- Amine oxidase (flavin-containing) A
- Amine oxidase [flavin-containing] B
- Butyrylcholinesterase (BChE)
- Monoamine Oxidase Type B (MAO-B)
- Monoamine oxidase
- (3R)-3-[methyl(prop-2-yn-1-yl)amino]-2,3-dihydro-1H-inden-5-yl N-ethyl-N-methylcarbamate
- 6-(N-methyl-N-ethyl-carbamoyloxy)-N-methyl-N-propargyl--1(R)-aminoindan
- Aminoindan deriv. (R)19b
- N-propargylaminoindan (R)19b
- R-M6CPAI
- rasagiline analog
- Coagulation factor X
- Coagulation factor XI
- Plasma kallikrein
- Plasminogen
- Transcription initiation factor IIA
- Vitamin K-dependent protein C
6 Ki
- US8598206, Table 6, 20
- Casein Kinase I
- Cyclin-Dependent Kinase 1 (CDK1)
- Cyclin-Dependent Kinase 5 (CDK5)
- Glycogen Synthase Kinase-3, beta
- cAMP-Dependent Protein Kinase (PKA)
- cGMP-Dependent Protein Kinase
6 IC50
- 3-(2-aminopyrimidin-4-yl)-6-bromo-1H-indol-4-ol
- Meridianin B
- Casein Kinase I
- Cyclin-Dependent Kinase 1 (CDK1)
- Cyclin-Dependent Kinase 5 (CDK5)
- Glycogen Synthase Kinase-3, beta
- cAMP-Dependent Protein Kinase (PKA)
- cGMP-Dependent Protein Kinase
6 IC50
- 3-(2-aminopyrimidin-4-yl)-7-bromo-1H-indol-4-ol
- Meridianin E
- Axin-1/Glycogen synthase kinase-3 beta
- Cyclin-Dependent Kinase 1 (CDK1)
- Cyclin-Dependent Kinase 5 (CDK5)
- Glycogen Synthase Kinase-3, beta
- cAMP-Dependent Protein Kinase (PKA)
- cGMP-Dependent Protein Kinase
6 IC50
- 4-(1H-indol-2-yl)pyrimidin-2-amine
- isomeridianin G
- CDK2/CycE
- Casein Kinase I
- Cyclin-Dependent Kinase 1 (CDK1)
- Cyclin-Dependent Kinase 5 (CDK5)
- Dual-specificity tyrosine-phosphorylation regulated kinase 1A
- Mitogen-activated protein kinase 1
6 IC50
- (2R)-2-{[6-(benzyloxy)-9-(propan-2-yl)-9H-purin-2-yl]amino}butan-1-ol
- O6-(R)-roscovitine
- R-2-(6-Benzyloxy-9-isopropyl-9H-purin-2-yl-amino)-butan-1-ol
- Amine oxidase (flavin-containing) A
- Amine oxidase [flavin-containing] B
- Monoamine Oxidase Type B (MAO-B)
- Monoamine oxidase type B (MAO-B) Mutant (I199F)
- Neuraminidase A
- Uridine-5'-diphosphoglucuronosyltransferase 1A1
- (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol
- trans,trans-Farnesol
- Carbonic Anhydrase XIV
- Carbonic anhydrase 1
- Carbonic anhydrase 12
- Carbonic anhydrase 2
- Carbonic anhydrase 7
- Carbonic anhydrase 9
8 Ki
- 1-Acetamido-5-sulfonamidoindane
- CHEMBL359768
- Indanesulfonamide Derivative 5
- N-(5-sulfamoyl-2,3-dihydro-1H-inden-1-yl)acetamide
- Carbonic Anhydrase XIV
- Carbonic anhydrase 1
- Carbonic anhydrase 12
- Carbonic anhydrase 2
- Carbonic anhydrase 7
- Carbonic anhydrase 9
8 Ki
- 2-acetamido-5-sulfonamidoindane
- CHEMBL184674
- Indanesulfonamide Derivative 6
- N-(5-sulfamoyl-2,3-dihydro-1H-inden-2-yl)acetamide
- Carbonic Anhydrase XIV
- Carbonic anhydrase 1
- Carbonic anhydrase 12
- Carbonic anhydrase 2
- Carbonic anhydrase 7
- Carbonic anhydrase 9
6 Ki
- 1-valproylamido-5-sulfonamidoindane
- 2-propyl-N-(5-sulfamoyl-2,3-dihydro-1H-inden-1-yl)pentanamide
- CHEMBL204941
- Indanesulfonamide Derivative 11a
- Carbonic Anhydrase XIV
- Carbonic anhydrase 1
- Carbonic anhydrase 12
- Carbonic anhydrase 2
- Carbonic anhydrase 7
- Carbonic anhydrase 9
6 Ki
- 2-propyl-N-(5-sulfamoyl-2,3-dihydro-1H-inden-2-yl)pentanamide
- 2-valproylamido-5-sulfonamidoindane
- CHEMBL381730
- Indanesulfonamide Derivative 12a
- Carbonic Anhydrase XIV
- Carbonic anhydrase 1
- Carbonic anhydrase 12
- Carbonic anhydrase 2
- Carbonic anhydrase 7
- Carbonic anhydrase 9
6 Ki
- 1-cyclohexylamido-5-sulfonamidoindane
- CHEMBL206830
- Indanesulfonamide Derivative 11b
- N-(5-sulfamoyl-2,3-dihydro-1H-inden-1-yl)cyclohexanecarboxamide
- Carbonic Anhydrase XIV
- Carbonic anhydrase 1
- Carbonic anhydrase 12
- Carbonic anhydrase 2
- Carbonic anhydrase 7
- Carbonic anhydrase 9
6 Ki
- 2-cyclohexylamido-5-sulfonamidoindane
- CHEMBL204990
- Indanesulfonamide Derivative 12b
- N-(5-sulfamoyl-2,3-dihydro-1H-inden-2-yl)cyclohexanecarboxamide
- Carbonic Anhydrase XIV
- Carbonic anhydrase 1
- Carbonic anhydrase 12
- Carbonic anhydrase 2
- Carbonic anhydrase 7
- Carbonic anhydrase 9
8 Ki
- 2,3,4,5,6-pentafluoro-N-(5-sulfamoyl-2,3-dihydro-1H-inden-2-yl)benzamide
- 2-pentafluorophenylamido-5-sulfonamidoindane
- CHEMBL184361
- Indanesulfonamide Derivative 12c
- Carbonic Anhydrase XIV
- Carbonic anhydrase 1
- Carbonic anhydrase 12
- Carbonic anhydrase 2
- Carbonic anhydrase 7
- Carbonic anhydrase 9
6 Ki
- 2-ethylamido-5-sulfonamidoindane
- CHEMBL204740
- Indanesulfonamide Derivative 12d
- N-(5-sulfamoyl-2,3-dihydro-1H-inden-2-yl)propanamide
- Carbonic Anhydrase XIV
- Carbonic anhydrase 1
- Carbonic anhydrase 12
- Carbonic anhydrase 2
- Carbonic anhydrase 7
- Carbonic anhydrase 9
6 Ki
- 2-propylamido-5-sulfonamidoindane
- CHEMBL205743
- Indanesulfonamide Derivative 12e
- N-(5-sulfamoyl-2,3-dihydro-1H-inden-2-yl)butanamide
- Carbonic Anhydrase XIV
- Carbonic anhydrase 1
- Carbonic anhydrase 12
- Carbonic anhydrase 2
- Carbonic anhydrase 7
- Carbonic anhydrase 9
6 Ki
- 2-butylamido-5-sulfonamidoindane
- CHEMBL208531
- Indanesulfonamide Derivative 12f
- N-(5-sulfamoyl-2,3-dihydro-1H-inden-2-yl)pentanamide
- Carbonic Anhydrase XIV
- Carbonic anhydrase 1
- Carbonic anhydrase 12
- Carbonic anhydrase 2
- Carbonic anhydrase 7
- Carbonic anhydrase 9
6 Ki
- 2-nonylamido-5-sulfonamidoindane
- CHEMBL208532
- Indanesulfonamide Derivative 12g
- N-(5-sulfamoyl-2,3-dihydro-1H-inden-2-yl)decanamide
- Carbonic anhydrase
- Carbonic anhydrase 1
- Carbonic anhydrase 2
- Carbonic anhydrase 9
- Carbonic anhydrase V
- Carbonic anhydrases; II & IX
10 Ki
- CHEMBL386049
- N-(4-sulfamoylphenyl)-2-sulfanylbenzamide
- reduced monomeric thio of compound 5a
- reduced thio H5a
- Cyclooxygenase
- Lipoxygenase (LOX)
- Nuclear factor erythroid 2-related factor 2
- Phospholipase A2
- Prostaglandin E synthase
- Prostaglandin G/H synthase (cyclooxygenase)
- (1Z,4Z)–1-5-Bis[2,3(dimethoxy)phenyl]-1,4- pentadien-3-one (9)
- Disintegrin and metalloproteinase domain-containing protein 10 (ADAM10)
- Disintegrin and metalloproteinase domain-containing protein 17
- Disintegrin and metalloproteinase domain-containing protein 9 (ADAM9)
- Interstitial collagenase
- Matrix metalloproteinase-9
- Stromelysin-1
9 IC50
- US8633196, 14
- US8633196, 5
- US9365529, 5
- Disintegrin and metalloproteinase domain-containing protein 10 (ADAM10)
- Disintegrin and metalloproteinase domain-containing protein 17
- Disintegrin and metalloproteinase domain-containing protein 9 (ADAM9)
- Interstitial collagenase
- Matrix metalloproteinase-9
- Stromelysin-1
7 IC50
- US8633196, 18
- US9365529, 18
- Disintegrin and metalloproteinase domain-containing protein 10 (ADAM10)
- Disintegrin and metalloproteinase domain-containing protein 17
- Disintegrin and metalloproteinase domain-containing protein 9 (ADAM9)
- Interstitial collagenase
- Matrix metalloproteinase-9
- Stromelysin-1
7 IC50
- US8633196, 19
- US9365529, 19
- Disintegrin and metalloproteinase domain-containing protein 10 (ADAM10)
- Disintegrin and metalloproteinase domain-containing protein 17
- Disintegrin and metalloproteinase domain-containing protein 9 (ADAM9)
- Interstitial collagenase
- Matrix metalloproteinase-9
- Stromelysin-1
7 IC50
- US8633196, 21
- US9365529, 21
- Disintegrin and metalloproteinase domain-containing protein 10 (ADAM10)
- Disintegrin and metalloproteinase domain-containing protein 17
- Disintegrin and metalloproteinase domain-containing protein 9 (ADAM9)
- Interstitial collagenase
- Matrix metalloproteinase-9
- Stromelysin-1
7 IC50
- US8633196, 23
- US9365529, 23
- Disintegrin and metalloproteinase domain-containing protein 10 (ADAM10)
- Disintegrin and metalloproteinase domain-containing protein 17
- Disintegrin and metalloproteinase domain-containing protein 9 (ADAM9)
- Interstitial collagenase
- Matrix metalloproteinase-9
- Stromelysin-1
8 IC50
- US8633196, 24
- US9365529, 24
- Disintegrin and metalloproteinase domain-containing protein 10 (ADAM10)
- Disintegrin and metalloproteinase domain-containing protein 17
- Disintegrin and metalloproteinase domain-containing protein 9 (ADAM9)
- Interstitial collagenase
- Matrix metalloproteinase-9
- Stromelysin-1
8 IC50
- US8633196, 26
- US9365529, 26
- Dipeptidyl peptidase 2 (DPP II)
- Dipeptidyl peptidase 4
- Dipeptidyl peptidase 9
- Dipeptidyl peptidase II and dipeptidyl peptidase IV (DPP2 and DPP4)
- Dipeptidyl peptidase IV
- Dipeptidyl peptidase VIII
- (2S,3S)-2-amino-3-methyl-1-(1,3-thiazolidin-3-yl)pentan-1-one
- BMCL15687 Compound 4
- CHEMBL98408
- P32-98
- thiazolidide 2
- Dipeptidyl peptidase 2 (DPP II)
- Dipeptidyl peptidase 4
- Dipeptidyl peptidase 9
- Dipeptidyl peptidase VIII
- Fibroblast Activation Protein (FAP)
- Fibroblast activation protein alpha
12 IC50
- (2S)-1-(2-{[4-(2,3-dihydro-1H-isoindol-2-yl)-2-methyl-4-oxobutan-2-yl]amino}acetyl)pyrrolidine-2-carbonitrile
- (2S)-Cyanopyrrolidine analogue 21d
- (2S)-cyanopyrrolidine 4
- 2-[3-[2-[2-Cyano-(S)-pyrrolidin-1-yl]-2-oxoethylamino]-3-methyl-1-oxobutyl]-1,3-dihydroisoindole
- Egl nine homolog 1
- Egl nine homolog 2
- Hypoxia-inducible factor 1 (FIH)
- Prolyl 3-hydroxylase OGFOD1
- Prolyl 4-hydroxylase
- Prolyl hydroxylase EGLN3
- US8653111, 72
- 72 kDa type IV collagenase
- Collagenase 3
- Interstitial collagenase
- Matrix metalloproteinase-9
- Neutrophil collagenase
- Stromelysin-1
6 Ki
- N-Hydroxy-4-{[(4-phenoxyphenyl)sulfonyl]methyl}-piperidine-4-carboxamide Hydrochloride
- N-hydroxy-4-{[(4-phenoxybenzene)sulfonyl]methyl}piperidine-4-carboxamide hydrochloride
- beta-sulfone 7b
- 72 kDa type IV collagenase
- Collagenase 3
- Interstitial collagenase
- Matrix metalloproteinase-9
- Neutrophil collagenase
- Stromelysin-1
6 Ki
- N-Hydroxy-1-(3-methoxybenzyl)-4-{[(4-phenoxyphenyl)-sulfonyl]methyl}piperidine-4-carboxamide Hydrochloride
- N-hydroxy-1-[(3-methoxyphenyl)methyl]-4-{[(4-phenoxybenzene)sulfonyl]methyl}piperidine-4-carboxamide hydrochloride
- beta-sulfone 7c
- 72 kDa type IV collagenase
- Collagenase 3
- Interstitial collagenase
- Matrix metalloproteinase-9
- Neutrophil collagenase
- Stromelysin-1
- CHEMBL234350
- N-Hydroxy-4-{[(4-phenoxyphenyl)sulfonyl]methyl}-1-(2-phenylethyl)piperidine-4-carboxamide Hydrochloride
- N-hydroxy-4-{[(4-phenoxybenzene)sulfonyl]methyl}-1-(2-phenylethyl)piperidine-4-carboxamide hydrochloride
- beta-sulfone 7d
- 72 kDa type IV collagenase
- Collagenase 3
- Interstitial collagenase
- Matrix metalloproteinase-9
- Neutrophil collagenase
- Stromelysin-1
- CHEMBL256157
- N-Hydroxy-4-{[(4-phenoxyphenyl)sulfonyl]methyl}-1-prop-2-ynylpiperidine-4-carboxamide Hydrochloride
- N-hydroxy-4-{[(4-phenoxybenzene)sulfonyl]methyl}-1-(prop-2-yn-1-yl)piperidine-4-carboxamide hydrochloride
- beta-sulfone 7e
- 72 kDa type IV collagenase
- Collagenase 3
- Interstitial collagenase
- Matrix metalloproteinase-9
- Neutrophil collagenase
- Stromelysin-1
6 Ki
- 4-({[4-(3,4-Dimethylphenoxy)phenyl]sulfonyl}methyl)-N-hydroxy-1-prop-2-ynylpiperidine-4-carboxamide Hydrochloride
- 4-({[4-(3,4-dimethylphenoxy)benzene]sulfonyl}methyl)-N-hydroxy-1-(prop-2-yn-1-yl)piperidine-4-carboxamide hydrochloride
- beta-sulfone 7f
- 72 kDa type IV collagenase
- Collagenase 3
- Interstitial collagenase
- Matrix metalloproteinase-9
- Neutrophil collagenase
- Stromelysin-1
6 Ki
- 1-N-Hydroxy-4-[(4-phenoxyphenyl)sulfonyl]piperidine-4-carboxamide
- N-hydroxy-4-[(4-phenoxybenzene)sulfonyl]piperidine-4-carboxamide
- alpha-sulfone 27b
- 72 kDa type IV collagenase
- Collagenase 3
- Interstitial collagenase
- Matrix metalloproteinase-9
- Neutrophil collagenase
- Stromelysin-1
6 Ki
- N-Hydroxy-1-(2-methoxyethyl)-4-{[4-(phenoxyphenyl]-sulfonyl}piperidine-4-carboxamide Hydrochloride
- N-hydroxy-1-(2-methoxyethyl)-4-[(4-phenoxybenzene)sulfonyl]piperidine-4-carboxamide hydrochloride
- alpha-sulfone 27d
- 72 kDa type IV collagenase
- Collagenase 3
- Interstitial collagenase
- Matrix metalloproteinase-9
- Neutrophil collagenase
- Stromelysin-1
6 Ki
- 1-Cyclopropyl-N-hydroxy-4-{[4-(phenoxyphenyl]-sulfonyl}piperidine-4-carboxamide Hydrochloride
- 1-cyclopropyl-N-hydroxy-4-[(4-phenoxybenzene)sulfonyl]piperidine-4-carboxamide hydrochloride
- alpha-sulfone 27e
- 72 kDa type IV collagenase
- Collagenase 3
- Interstitial collagenase
- Matrix metalloproteinase-9
- Neutrophil collagenase
- Stromelysin-1
6 Ki
- N-Hydroxy-4-{[4-(phenoxyphenyl]sulfonyl}-1- (2-propynyl)4-piperidinecarboxamide, Monohydrochloride
- N-hydroxy-4-[(4-phenoxybenzene)sulfonyl]-1-(prop-2-yn-1-yl)piperidine-4-carboxamide hydrochloride
- alpha-sulfone 27g
- 72 kDa type IV collagenase
- Collagenase 3
- Interstitial collagenase
- Matrix metalloproteinase-9
- Neutrophil collagenase
- Stromelysin-1
6 Ki
- N-Hydroxy-1-methyl-4-{[4-(phenylthio)phenyl]sulfonyl}-piperidine-4-carboxamide Hydrochloride
- N-hydroxy-1-methyl-4-{[4-(phenylsulfanyl)benzene]sulfonyl}piperidine-4-carboxamide hydrochloride
- alpha-sulfone 35a
- 72 kDa type IV collagenase
- Collagenase 3
- Interstitial collagenase
- Matrix metalloproteinase-9
- Neutrophil collagenase
- Stromelysin-1
6 Ki
- N-Hydroxy-1-(2-methoxyethyl)-4-{[4-(phenylthio)-phenyl]sulfonyl}piperidine-4-carboxamide Hydrochloride
- N-hydroxy-1-(2-methoxyethyl)-4-{[4-(phenylsulfanyl)benzene]sulfonyl}piperidine-4-carboxamide hydrochloride
- alpha-sulfone 35c
- 72 kDa type IV collagenase
- Collagenase 3
- Interstitial collagenase
- Matrix metalloproteinase-9
- Neutrophil collagenase
- Stromelysin-1
6 Ki
- 1-Cyclopropyl-N-hydroxy-4-{[4-(phenylthio)phenyl]-sulfonyl}piperidine-4-carboxamide Hydrochloride
- 1-cyclopropyl-N-hydroxy-4-{[4-(phenylsulfanyl)benzene]sulfonyl}piperidine-4-carboxamide hydrochloride
- alpha-sulfone 35d
- 72 kDa type IV collagenase
- Collagenase 3
- Interstitial collagenase
- Matrix metalloproteinase-9
- Neutrophil collagenase
- Stromelysin-1
6 Ki
- 1-Acetyl-N-hydroxy-4-{[4-(phenylthio)phenyl]sulfonyl}-piperidine-4-carboxamide
- 1-acetyl-N-hydroxy-4-{[4-(phenylsulfanyl)benzene]sulfonyl}piperidine-4-carboxamide
- alpha-sulfone 35g
- 72 kDa type IV collagenase
- Collagenase 3
- Interstitial collagenase
- Matrix metalloproteinase-9
- Neutrophil collagenase
- Stromelysin-1
6 Ki
- N-Hydroxy-1-(methylsulfonyl)-4-{[4-(phenylthio)phenyl]-sulfonyl}piperidine-4-carboxamide
- N-hydroxy-1-methanesulfonyl-4-{[4-(phenylsulfanyl)benzene]sulfonyl}piperidine-4-carboxamide
- alpha-sulfone 35h
- Cereblon/Histone deacetylase 6
- Histone deacetylase 1
- Histone deacetylase 2
- Histone deacetylase 3
- Histone deacetylase 8
- Prostaglandin E2 receptor EP2 subtype
- BDBM119693
- US8685986, 12
- Cereblon/Histone deacetylase 6
- Histone deacetylase 1
- Histone deacetylase 2
- Histone deacetylase 3
- Histone deacetylase 8
- Prostaglandin E2 receptor EP2 subtype
- BDBM119694
- US8685986, 13
- CDK2/CycE
- Cyclin-Dependent Kinase 1 (CDK1)
- Cyclin-Dependent Kinase 2 (CDK2)
- Cyclin-Dependent Kinase 4 (CDK4)
- Cyclin-Dependent Kinase 7 (CDK7)
- Cyclin-Dependent Kinase 9 (CDK9)
6 IC50
- 4-Arylazo-3,5-diamino-1H-pyrazole 1b
- 4-[(E)-2-phenyldiazen-1-yl]-1H-pyrazole-3,5-diamine
- CDK2/CycE
- Cyclin-Dependent Kinase 1 (CDK1)
- Cyclin-Dependent Kinase 2 (CDK2)
- Cyclin-Dependent Kinase 4 (CDK4)
- Cyclin-Dependent Kinase 7 (CDK7)
- Cyclin-Dependent Kinase 9 (CDK9)
6 IC50
- 4-Arylazo-3,5-diamino-1H-pyrazole 26b
- 4-[(E)-2-(2-nitrophenyl)diazen-1-yl]-1H-pyrazole-3,5-diamine
- CDK2/CycE
- Cyclin-Dependent Kinase 1 (CDK1)
- Cyclin-Dependent Kinase 2 (CDK2)
- Cyclin-Dependent Kinase 4 (CDK4)
- Cyclin-Dependent Kinase 7 (CDK7)
- Cyclin-Dependent Kinase 9 (CDK9)
6 IC50
- 4-Arylazo-3,5-diamino-1H-pyrazole 27b
- 4-[(E)-2-(3-nitrophenyl)diazen-1-yl]-1H-pyrazole-3,5-diamine
- Activin receptor type-1
- Activin receptor type-1B
- Activin receptor type-1B/Activin receptor-like kinase 4 (ALK-4)
- Activin receptor-like kinase 3 (ALK-3)
- Serine/threonine-protein kinase receptor R3
- Serine/threonine-protein kinase receptor R3 (ALK1)
8 IC50
- US10017516, Compound 5
- US9682983, 5
- CDK2/CycE
- Cyclin-Dependent Kinase 1 (CDK1)
- Cyclin-Dependent Kinase 2 (CDK2)
- Cyclin-Dependent Kinase 4 (CDK4)
- Cyclin-Dependent Kinase 7 (CDK7)
- Cyclin-Dependent Kinase 9 (CDK9)
6 IC50
- 3-[(E)-2-(3,5-diamino-1H-pyrazol-4-yl)diazen-1-yl]phenol
- 4-Arylazo-3,5-diamino-1H-pyrazole 30b
- CDK2/CycE
- Cyclin-Dependent Kinase 1 (CDK1)
- Cyclin-Dependent Kinase 2 (CDK2)
- Cyclin-Dependent Kinase 4 (CDK4)
- Cyclin-Dependent Kinase 7 (CDK7)
- Cyclin-Dependent Kinase 9 (CDK9)
6 IC50
- 4-Arylazo-3,5-diamino-1H-pyrazole 35b
- {2-[(E)-2-(3,5-diamino-1H-pyrazol-4-yl)diazen-1-yl]phenyl}methanol
- Cathepsin K
- Cruzipain
- Cysteine protease falcipain-2
- Cysteine protease falcipain-3
- Falcipain 2
- Falcipain-2
- (2R,3R)-3-{[(1S)-1-[(4-carbamimidamidobutyl)carbamoyl]-3-methylbutyl]carbamoyl}oxirane-2-carboxylic acid
- E-64
- L-trans-3-Carboxyoxiran-2-carbonyl-L-leucylagmatine
- N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO-BUTYL]-GUANIDINE
- trans-Epoxysuccinyl-L-leucylamido(4-guanidino)butane
- 72 kDa type IV collagenase
- Collagenase 3
- Interstitial collagenase
- Matrix metalloproteinase-7 (MMP7)
- Matrix metalloproteinase-9
- Stromelysin-1
- (2R)-2-{[4-(4-bromophenyl)benzene]sulfonamido}-3-methylbutanoic acid
- CHEMBL42420
- alpha-arylsulfonylamino carboxylate 2R
- 72 kDa type IV collagenase
- Collagenase 3
- Interstitial collagenase
- Matrix metalloproteinase-7 (MMP7)
- Matrix metalloproteinase-9
- Stromelysin-1
8 IC50
- (2R)-2-{[4-(4-bromophenyl)benzene]sulfonamido}-N-hydroxy-3-methylbutanamide
- CHEMBL433262
- alpha-arylsulfonylamino hydroxamate 3R
- 72 kDa type IV collagenase
- Collagenase 3
- Interstitial collagenase
- Matrix metalloproteinase-7 (MMP7)
- Matrix metalloproteinase-9
- Stromelysin-1
8 IC50
- (2S)-2-{[4-(4-bromophenyl)benzene]sulfonamido}-N-hydroxy-3-methylbutanamide
- CHEMBL43644
- alpha-arylsulfonylamino hydroxamate 3S
- Cytochrome P450 2C9
- Cytochrome P450 2D6 (2D6)
- Cytochrome P450 3A
- Orexin receptor type 1
- Orexin receptor type 1 (OX1)
- Orexin receptor type 2
- US8710076, E-2
- Aurora kinase A/Targeting protein for Xklp2
- CDK2/CycE
- Cyclin-Dependent Kinase 1 (CDK1)
- Cyclin-Dependent Kinase 2 (CDK2)
- Cyclin-Dependent Kinase 4 (CDK4)
- Cyclin-Dependent Kinase 5 (CDK5)
6 IC50
- 3-Amino-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole 15
- N-butyl-3-{2-[4-(pyrrolidin-1-yl)phenyl]acetamido}-1H,4H,5H,6H-pyrrolo[3,4-c]pyrazole-5-carboxamide
- Aurora kinase A/Targeting protein for Xklp2
- CDK2/CycE
- Cyclin-Dependent Kinase 1 (CDK1)
- Cyclin-Dependent Kinase 2 (CDK2)
- Cyclin-Dependent Kinase 4 (CDK4)
- Cyclin-Dependent Kinase 5 (CDK5)
6 IC50
- 3-Amino-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole 18
- N-butyl-3-[(2S)-2-(naphthalen-2-yl)propanamido]-1H,4H,5H,6H-pyrrolo[3,4-c]pyrazole-5-carboxamide
- Cytochrome P450 2C9
- Cytochrome P450 2D6 (2D6)
- Cytochrome P450 3A
- Orexin receptor type 1
- Orexin receptor type 2
- Potassium voltage-gated channel subfamily H member 2
- US8742106, 1.4
- Cytochrome P450 2C9
- Cytochrome P450 2D6 (2D6)
- Cytochrome P450 3A
- Orexin receptor type 1
- Orexin receptor type 2
- Potassium voltage-gated channel subfamily H member 2
- US8742106, 1.6
- 1,3-beta-glucan synthase component GLS2
- G-protein coupled receptor 4
- G-protein coupled receptor 4 (GPR4)
- Histamine H3 receptor
- Ovarian cancer G-protein coupled receptor 1
- Psychosine receptor
9 IC50
- US8748435, 35
- 5-hydroxytryptamine receptor 1A
- 5-hydroxytryptamine receptor 2A
- 5-hydroxytryptamine receptor 2C
- D(2) dopamine receptor
- D(3) dopamine receptor
- D(4) dopamine receptor
- US8748608, 34
- US8748608, 34 Enantiomer A
- US8748608, 34 Enantiomer B
- Cereblon/Histone deacetylase 6
- Histone deacetylase 1
- Histone deacetylase 2
- Histone deacetylase 3
- Histone deacetylase 4
- Histone deacetylase 5
6 IC50
- US8748458, 3
- Cytochrome P450 2B6
- Cytochrome P450 2D6
- Poly [ADP-ribose] polymerase 1
- Poly [ADP-ribose] polymerase 2
- Poly [ADP-ribose] polymerase tankyrase-1
- Protein mono-ADP-ribosyltransferase PARP3
- US8765972, 3
- Cytochrome P450 2B6
- Cytochrome P450 2D6
- Poly [ADP-ribose] polymerase 1
- Poly [ADP-ribose] polymerase 2
- Poly [ADP-ribose] polymerase tankyrase-1
- Protein mono-ADP-ribosyltransferase PARP3
- US8765972, 4
- Coagulation factor IX
- Coagulation factor VII
- Coagulation factor X
- Plasma kallikrein
- Prothrombin
- Trypsin
8 Ki
- 1-(3-Aminobenzisoxazol-5-yl)-3-trifluoromethyl-5-[(2-methylsulfonyl-3-fluoro[1,1]biphen-4-yl)aminocarbonyl]-pyrazole, Trifluoroacetic Acid
- 1-(3-amino-1,2-benzoxazol-5-yl)-N-[2-fluoro-4-(2-methanesulfonylphenyl)phenyl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide; 2,2,2-trifluoroacetic acid
- CHEMBL554926
- Razaxaban Analogue
- aminobenzisoxazole 38
- Coagulation factor IX
- Coagulation factor X
- Prothrombin
- Trypsin
- Trypsin II
- Trypsin-1
24 Ki
- 1-(3-carbamimidoylphenyl)-3-methyl-N-[4-(2-sulfamoylphenyl)phenyl]-1H-pyrazole-5-carboxamide
- CHEMBL152854
- CHEMBL37251
- SN-429
- High affinity nerve growth factor receptor
- Non-receptor tyrosine-protein kinase TYK2
- Tyk2
- Tyrosine-protein kinase JAK1
- Tyrosine-protein kinase JAK2
- Tyrosine-protein kinase JAK3
12 IC50
- US8791123, 181
- US9782415, Example 181
- HIV-1 Protease
- HIV-1 Protease Mutant M1 (L10I, G48V, I54V, L63P, V82A)
- HIV-1 Protease Mutant M2 (D30N, L63P, N88D)
- HIV-1 Protease Mutant M3 (L10I, L63P, A71V, G73S, I84V, L90M)
- HIV-1 protease
- Protease
8 Ki
- (5S)-3-(3-Acetylphenyl)-N-[(1S,2R)-1-benzyl-2-hydroxy-3-[isobutyl[(4-methoxyphenyl)sulfonyl]amino]propyl]-2-oxooxazolidine-5-carboxamide
- (5S)-3-(3-acetylphenyl)-N-[(2S,3R)-3-hydroxy-4-[(4-methoxybenzene)(2-methylpropyl)sulfonamido]-1-phenylbutan-2-yl]-2-oxo-1,3-oxazolidine-5-carboxamide
- N-Aryl-oxazolidinone-5-carboxamide Analogue 21e
- HIV-1 Protease
- HIV-1 Protease Mutant M1 (L10I, G48V, I54V, L63P, V82A)
- HIV-1 Protease Mutant M2 (D30N, L63P, N88D)
- HIV-1 Protease Mutant M3 (L10I, L63P, A71V, G73S, I84V, L90M)
- HIV-1 protease
- Protease
7 Ki
- (5S)-N-[(1S,2R)-3-[[(4-Aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroxypropyl]-2-oxo-3-phenyloxazolidine-5-carboxamide
- (5S)-N-[(2S,3R)-4-[(4-aminobenzene)(2-methylpropyl)sulfonamido]-3-hydroxy-1-phenylbutan-2-yl]-2-oxo-3-phenyl-1,3-oxazolidine-5-carboxamide
- N-Aryl-oxazolidinone-5-carboxamide Analogue 25a
- HIV-1 Protease
- HIV-1 Protease Mutant M1 (L10I, G48V, I54V, L63P, V82A)
- HIV-1 Protease Mutant M2 (D30N, L63P, N88D)
- HIV-1 Protease Mutant M3 (L10I, L63P, A71V, G73S, I84V, L90M)
- HIV-1 protease
- Protease
7 Ki
- (5S)-3-(3-Acetylphenyl)-N-[(1S,2R)-3-[[(benzo[1,3]dioxole-5-sulfonyl)](isobutyl)amino]-1-benzyl-2-hydroxypropyl]-2-oxooxazolidine-5-carboxamide
- (5S)-N-[(2S,3R)-4-[2H-1,3-benzodioxole-5-(2-methylpropyl)sulfonamido]-3-hydroxy-1-phenylbutan-2-yl]-3-(3-acetylphenyl)-2-oxo-1,3-oxazolidine-5-carboxamide
- N-Aryl-oxazolidinone-5-carboxamide Analogue 26e
- Nitric Oxide Synthase, endothelial
- Nitric oxide synthase mutant (eNOS L111A)
- Nitric oxide synthase mutant (eNOS Y477A)
- Nitric oxide synthase mutant (nNOS H341L)
- Nitric oxide synthase mutant (nNOS M336V/D597N)
- Nitric-oxide synthase, brain
6 Kd
- 6({[(2R,4S)4{[(6amino4methylpyridin2 yl)oxy]methyl}pyrrolidin2yl]methoxy}methyl)4 methylpyridin2amine ((2R,4S)-6)
- Nitric Oxide Synthase, endothelial
- Nitric oxide synthase mutant (eNOS Y477A)
- Nitric oxide synthase mutant (nNOS H341L)
- Nitric oxide synthase mutant (nNOS M336V/D597N)
- Nitric oxide synthase, inducible
- Nitric-oxide synthase, brain
6 Kd
- 6(3amino2{5[2(6amino4methylpyridin2 yl)ethyl]pyridin3yl}propyl)4methylpyridin2amine (7)
- Aromatase cytochrome P450
- Bile salt export pump
- Carbonic anhydrase 2
- Cytochrome P450 11B1, mitochondrial
- Cytochrome P450 11B2 (CYP11B2)
- Cytochrome P450 19A1
- 4,4 -(1H-1,2,4-triazol-1-ylmethanediyl)dibenzonitrile
- 4-[(4-cyanophenyl)(1H-1,2,4-triazol-1-yl)methyl]benzonitrile
- CHEMBL1444
- Letrozole
- BDNF/NT-3 growth factors receptor
- High affinity nerve growth factor receptor
- NT-3 growth factor receptor
- Proto-oncogene tyrosine-protein kinase ROS
- Proto-oncogene tyrosine-protein kinase receptor Ret
- Serine/threonine-protein kinase receptor R3
6 IC50
- US8822500, [4]
- BDNF/NT-3 growth factors receptor
- High affinity nerve growth factor receptor
- NT-3 growth factor receptor
- Proto-oncogene tyrosine-protein kinase ROS
- Proto-oncogene tyrosine-protein kinase receptor Ret
- Serine/threonine-protein kinase receptor R3
6 IC50
- US8822500, [1]
- HIV-1 Reverse Transcriptase
- HIV-1 Reverse Transcriptase Mutant (K103N)
- HIV-1 Reverse Transcriptase Mutant (L100I)
- HIV-1 Reverse Transcriptase Mutant (P236L)
- HIV-1 Reverse Transcriptase Mutant (Y181C)
- Human immunodeficiency virus type 1 reverse transcriptase
21 IC50
- 3-[[(4,7-Dichlorobenzoxazol-2-yl)-methyl]amino]-5-ethyl-6-methylpyridin-2(1H)-one
- 3-{[(4,7-dichloro-1,3-benzoxazol-2-yl)methyl]amino}-5-ethyl-6-methyl-1,2-dihydropyridin-2-one
- CHEMBL268871
- L-697,661
- Pyridinone deriv.
- 3',5'-cyclic phosphodiesterase
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B (PDE4B2)
- cAMP-specific 3',5'-cyclic phosphodiesterase 4D
- phosphodiesterase 4B2
- phosphodiesterase 4D
10 IC50
- US10085990, Example 121
- US10568888, Example 121
- US8853226, 121
- US9393245, 121
- US9833457, 121
- 3',5'-cyclic phosphodiesterase
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B (PDE4B2)
- cAMP-specific 3',5'-cyclic phosphodiesterase 4D
- phosphodiesterase 4B2
- phosphodiesterase 4D
10 IC50
- US10085990, Example 122
- US10568888, Example 122
- US8853226, 122
- US9393245, 122
- US9833457, 122
- Coagulation factor VII
- Coagulation factor X
- Coagulation factor XI
- Prothrombin
- Tissue-type plasminogen activator
- Trypsin
- 2-{2-[(4-carbamimidoylphenyl)carbamoyl]-6-methoxypyridin-3-yl}-5-{[(2S)-1-hydroxy-3,3-dimethylbutan-2-yl]carbamoyl}benzoic acid
- Ono Compound 8
- Proto-oncogene tyrosine-protein kinase receptor Ret
- Tyrosine-protein kinase JAK2
- Tyrosine-protein kinase JAK3
- Tyrosine-protein kinase SYK
- Tyrosine-protein kinase ZAP-70
- Vascular endothelial growth factor receptor 2
8 IC50
- US8871778, 189
- Cereblon/Histone deacetylase 1
- Cereblon/Histone deacetylase 2
- Cereblon/Histone deacetylase 6
- Histone deacetylase 1
- Histone deacetylase 2
- Histone deacetylase 3
12 IC50
- US10858323, Compound 1
- US8614223, 73
- Conantokin-G
- Conantokin-T
- Outer Membrane Phospholipase A
- PLD alpha C2
- PLD beta C2
- cPLA2 C2
8 ΔG°
- Ca2+
- calcium
- Cyclin-dependent kinase 2
- Dual-specificity tyrosine-phosphorylation regulated kinase 1A
- Rho-associated protein kinase 1
- Rho-associated protein kinase 2
- Ribosomal protein S6 kinase (P70S6K)
- Ribosomal protein S6 kinase alpha 5
9 IC50
- 4-(1-ethyl-1H-imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine
- 4-{1-ethyl-1H-imidazo[4,5-c]pyridin-2-yl}-1,2,5-oxadiazol-3-amine
- Aminofurazanyl-azabenzimidazole 1
- CHEMBL189657
- Androgen Receptor
- Baculoviral IAP repeat-containing protein 2/Estrogen receptor
- Estrogen receptor
- Glucocorticoid receptor
- Mineralocorticoid receptor
- Progesterone receptor
12 IC50
- US8916600, 2
- US8916600, 3
- US9738632, Example 2
- Androgen Receptor
- Baculoviral IAP repeat-containing protein 2/Estrogen receptor
- Estrogen receptor
- Glucocorticoid receptor
- Mineralocorticoid receptor
- Progesterone receptor
11 IC50
- US8916600, 6
- US9738632, Example 6
- Androgen Receptor
- Baculoviral IAP repeat-containing protein 2/Estrogen receptor
- Estrogen receptor
- Glucocorticoid receptor
- Mineralocorticoid receptor
- Progesterone receptor
11 IC50
- US8916600, 12
- US9738632, Example 12
- Androgen Receptor
- Baculoviral IAP repeat-containing protein 2/Estrogen receptor
- Estrogen receptor
- Glucocorticoid receptor
- Mineralocorticoid receptor
- Progesterone receptor
11 IC50
- US8916600, 13
- US9738632, Example 13
- Coagulation factor X
- Plasminogen
- Prothrombin
- Tissue-type plasminogen activator
- Trypsin
- Urokinase-type plasminogen activator
6 Ki
- APC-9008
- {amino[2-(3,5-dichloro-2-hydroxyphenyl)-1H-indol-5-yl]methylidene}azanium
- Coagulation factor X
- Plasminogen
- Prothrombin
- Tissue-type plasminogen activator
- Trypsin
- Urokinase-type plasminogen activator
18 Ki
- APC-10818
- {amino[6-fluoro-2-(2-hydroxy-3-phenylphenyl)-1H-1,3-benzodiazol-5-yl]methylidene}azanium
- JAK3/JAK1
- Non-receptor tyrosine-protein kinase TYK2
- Potassium voltage-gated channel subfamily H member 2
- Tyrosine-protein kinase JAK1
- Tyrosine-protein kinase JAK2
- Tyrosine-protein kinase JAK3
8 IC50
- US8921368, 192
- JAK3/JAK1
- Non-receptor tyrosine-protein kinase TYK2
- Potassium voltage-gated channel subfamily H member 2
- Tyrosine-protein kinase JAK1
- Tyrosine-protein kinase JAK2
- Tyrosine-protein kinase JAK3
8 IC50
- US8921368, 195
- Coagulation factor X
- Plasminogen
- Prothrombin
- Tissue-type plasminogen activator
- Trypsin
- Urokinase-type plasminogen activator
18 Ki
- 6-fluoro-2-(2-hydroxy-3-{[(1S,2S)-2-methylcyclohexyl]oxy}phenyl)-1H-indole-5-carboximidamide
- APC-11092
- Coagulation factor X
- Plasminogen
- Prothrombin
- Tissue-type plasminogen activator
- Trypsin
- Urokinase-type plasminogen activator
18 Ki
- 2-{5-[amino(iminiumyl)methyl]-6-chloro-1H-1,3-benzodiazol-2-yl}-6-(2-methylpropoxy)benzen-1-olate
- APC-10972
- Coagulation factor X
- Plasminogen
- Prothrombin
- Tissue-type plasminogen activator
- Trypsin
- Urokinase-type plasminogen activator
11 Ki
- 3-bromo-N-(4-carbamimidoylphenyl)-2-hydroxy-5-methylbenzamide
- APC-10484
- CHEMBL61327
- Coagulation factor X
- Plasminogen
- Prothrombin
- Tissue-type plasminogen activator
- Trypsin
- Urokinase-type plasminogen activator
11 Ki
- APC-10605
- CHEMBL64097
- N-(4-carbamimidoylphenyl)-2-hydroxy-3-iodo-5-methylbenzamide
- Coagulation factor X
- Plasminogen
- Prothrombin
- Tissue-type plasminogen activator
- Trypsin
- Urokinase-type plasminogen activator
11 Ki
- APC-11922
- CHEMBL293260
- N-(4-carbamimidoyl-3-fluorophenyl)-2-hydroxy-3-iodo-5-methylbenzamide
- Coagulation factor X
- Plasminogen
- Prothrombin
- Tissue-type plasminogen activator
- Trypsin
- Urokinase-type plasminogen activator
11 Ki
- APC-11421
- CHEMBL62897
- N-(4-carbamimidoyl-3-chlorophenyl)-2-hydroxy-3-iodo-5-methylbenzamide
- N-{4-[amino(imino)methyl]-3-chlorophenyl}-2-hydroxy-3-iodo-5-methylbenzamide
- Coagulation factor X
- Prothrombin
- Tissue-type plasminogen activator
- Trypsin
- Tryptase
- Urokinase-type plasminogen activator
6 Ki
- APC-7377
- Benzo[b]thiophene-2-carboxamidine
- [amino(1-benzothiophen-2-yl)methylidene]azanium
- Coagulation factor X
- Prothrombin
- Tissue-type plasminogen activator
- Trypsin
- Tryptase
- Urokinase-type plasminogen activator
6 Ki
- APC-7538
- Thieno[2,3-b]pyridine-2-carboxamidine
- [amino(thieno[2,3-b]pyridin-2-yl)methylidene]azanium
- Coagulation factor VII
- Coagulation factor X
- Prothrombin
- Trypsin
- Tryptase
- Tryptase beta-1/beta-2
6 Ki
- CHEMBL214368
- CRA23
- ethyl N-[(2S)-6-amino-1-(5-{[4-(2,3-dihydro-1H-inden-2-ylcarbamoyl)phenyl]methyl}-1,2,4-oxadiazol-3-yl)-1-oxohexan-2-yl]carbamate
- Activin receptor type-1
- Activin receptor type-1B
- Activin receptor type-1B/Activin receptor-like kinase 4 (ALK-4)
- Activin receptor-like kinase 3 (ALK-3)
- Bone morphogenetic protein receptor type-1B (BMPR1B) aa 168-495
- TGF-beta receptor type-1
10 IC50
- US10017516, Compound 12
- US9682983, 12
- HIV-1 Reverse Transcriptase
- HIV-1 Reverse Transcriptase Mutant (K103N)
- HIV-1 Reverse Transcriptase Mutant (P236L)
- HIV-1 Reverse Transcriptase Mutant (Y181C)
- Human immunodeficiency virus type 1 reverse transcriptase
- Reverse transcriptase
11 IC50
- 5-methoxyindole-2-carboxylic acid [N -[3-(aminoethyl)pyridin-2-yl]piperazide]
- BHAP deriv.
- CHEMBL280527
- CHEMBL7264
- N-ethyl-2-{4-[(5-methoxy-1H-indol-2-yl)carbonyl]piperazin-1-yl}pyridin-3-amine
- U-87201E
- bis(heteroaryl)piperazine analog
- Activin receptor type-1
- Activin receptor type-1B
- Activin receptor type-1B/Activin receptor-like kinase 4 (ALK-4)
- Bone morphogenetic protein receptor type-1B (BMPR1B) aa 168-495
- Serine/threonine-protein kinase receptor R3
- Serine/threonine-protein kinase receptor R3 (ALK1)
8 IC50
- US10017516, Compound 15
- US9682983, 15
- D(2) dopamine receptor
- Somatostatin receptor type 1
- Somatostatin receptor type 2
- Somatostatin receptor type 3
- Somatostatin receptor type 4
- Somatostatin receptor type 5
6 Ki
- US8952128, 4
- D(2) dopamine receptor
- Somatostatin receptor type 1
- Somatostatin receptor type 2
- Somatostatin receptor type 3
- Somatostatin receptor type 4
- Somatostatin receptor type 5
6 Ki
- US8952128, 5
- D(2) dopamine receptor
- Somatostatin receptor type 1
- Somatostatin receptor type 2
- Somatostatin receptor type 3
- Somatostatin receptor type 4
- Somatostatin receptor type 5
6 Ki
- US8952128, 6
- D(2) dopamine receptor
- Somatostatin receptor type 1
- Somatostatin receptor type 2
- Somatostatin receptor type 3
- Somatostatin receptor type 4
- Somatostatin receptor type 5
6 Ki
- US8952128, 7
- D(2) dopamine receptor
- Somatostatin receptor type 1
- Somatostatin receptor type 2
- Somatostatin receptor type 3
- Somatostatin receptor type 4
- Somatostatin receptor type 5
6 Ki
- US8952128, 8
- D(2) dopamine receptor
- Somatostatin receptor type 1
- Somatostatin receptor type 2
- Somatostatin receptor type 3
- Somatostatin receptor type 4
- Somatostatin receptor type 5
6 Ki
- US8952128, 9
- D(2) dopamine receptor
- Somatostatin receptor type 1
- Somatostatin receptor type 2
- Somatostatin receptor type 3
- Somatostatin receptor type 4
- Somatostatin receptor type 5
6 Ki
- US8952128, 10